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Background
Fabry disease is a rare X-linked condition that results in
storage of sphingolipids in multiple organs including the
heart. The cardiac phenotype consists mainly of conduc-
tion abnormalities, left ventricular hypertrophy (LVH)
and disease progression (fibrosis, arrhythmias and heart
failure).
CMR LGE classically shows basal inferolateral LGE.
Native T1 mapping has recently shown a low T1 likely
to represent myocycte storage of fat, even when no
LVH is present. We sought to understand the relation-
ship of storage to LVH and ECG abnormalities.
Methods
67 genetically confirmed Fabry disease patients under-
went CMR (function, T1 mapping, LGE) on a 1.5T
Siemens Avanto with a concurrent 12 lead ECG. LVH
was defined by mass index (LVMi) and a wall thickness
≥12 mm. Native T1 mapping used ShMOLLI with a
region of interest drawn in the septum in a basal short
axis view, and 900 ms considered the lower limit of nor-
mal. An abnormal ECG was defined by a prolonged PR
interval (>200 ms), prolonged QRS duration (>120 ms),
the presence of T-wave inversions, and/or LVH by
Sokolow criteria.
Results
The 67 Fabry patients had a mean age of 46 ± 14 years,
females 70% (47/67), and good LV function (LVEF 76 ±
7%). LVH was present in 43% (29/67) by wall thickness
and 48% (32/67) by mass index.
T1 with LVH: 69% (46/67) had low native T1 values.
Low T1 was more common in LVH positive than LVH
negative subjects (86% vs 55%, mean 854 ± 53 vs 897 ±
46 ms, p = 0.001). However, 55% (21/38) of the LVH-
negative subjects had low T1 values, and 14% (4/29) of
LVH-positive subjects had a normal T1.
T1 with ECG: 64% (43/67) had abnormal ECGs,
(Table 1; results stratified by T1 and LVH). ECG
abnormalities were highly correlated to LVH by wall
thickness (13 ± 9 vs 9 ± 2 mm, p < 0.001) and LVMi
(98 ± 36 vs 67 ± 22 g/m2, p = 0.001) with lower T1
values in those with ECG abnormalities (863 ± 52 vs
906 ± 44 ms, p = 0.001).
In subjects without LVH, when the T1 was low, 12/21
(58%) had an abnormal ECG, and 6/17 (33%) when the
T1 was normal.
Conclusions
In gene positive Fabry disease subjects, LVH has a low T1
85% of the time, but half of all LVH-negative patients
have a low T1. When there is no LVH, ECG abnormal-
ities are slightly more common in those with a low T1 -
but up to 1 in 3 have ECG abnormalities before apparent
storage. The most plausible explanations for this are
either that T1 can miss some storage, or that there may
be other Fabry effects other than storage - (toxic metabo-
lites are proposed).
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Table 1 Differences in ECG changes between Fabry patients with and without low T1 values
Low T1 Normal T1 p-wave LVH-positive LVH-negative p-wave
P-wave duration (ms) 98 ± 20 85 ± 24 0.02 101 ± 22 89 ± 21 0.03
PR interval (ms) 152 ± 31 158 ± 37 NS 156 ± 29 153 ± 36 NS
P-wave to PR interval ratio (%) 67 ± 17 55 ± 12 0.004 67 ± 20 59 ± 13 0.05
QRS duration (ms) 98 ± 24 86 ± 11 0.03 109 ± 24 83 ± 9 <0.001
T-wave inversions (n) 25 7 NS 22 10 <0.001
Sokolow (mm) 33 ± 16 29 ± 10 NS 33 ± 14 31 ± 14 NS
Figure 1 Normal ECG in Fabry disease patient without left ventricular hypertrophy (wall thickness of 10 mm) but low T1 of 889 ms.
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